Literature DB >> 1766672

High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif.

R J Fisher1, G Mavrothalassitis, A Kondoh, T S Papas.   

Abstract

ETS1 protein purified from CEM cells was used to select its optimum DNA-binding sequence (pu) G/CCaGGA-AGTc (py). The sequence CCGGAAGT (ETS1-3) was preferred 5:1 over CAGGAAGT (PEA3). Quantitative electrophoretic mobility-shift assays (EMSA) indicated that the purified ETS1 protein binds to either ETS1-3 or PEA3 oligonucleotide probes with high affinity (Ka = 0.5-4.0 x 10(10) M-1) and that the purified ETS1 has different binding capacities for ETS1-3 and PEA3 oligonucleotide probes. The ETS1 protein binds 2-5 times more ETS1-3 than PEA3. Competitive binding experiments showed that the ETS1-3 and PEA3 probes effectively compete for the binding of ETS1-3. However, changing the core DNA-binding sequence from GGAA to AGAA eliminates competition. Since the human ETS1 protein selected the same DNA sequence from a mixture of random oligonucleotides as did the Drosophila E74A protein (one of the most divergent members of the ETS family), this strongly suggests that all proteins containing the ETS 85 amino acid domain (sequences which define the ETS family) will bind to the same sequence.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1766672

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele.

Authors:  T F Fitzmaurice; R J Desnick; D F Bishop
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis.

Authors:  Sarah Bradshaw; W Jim Zheng; Lam C Tsoi; Gary Gilkeson; Xian K Zhang
Journal:  Clin Immunol       Date:  2008-08-09       Impact factor: 3.969

3.  Correction of the NMR structure of the ETS1/DNA complex.

Authors:  M H Werner; G M Clore; C L Fisher; R J Fisher; L Trinh; J Shiloach; A M Gronenborn
Journal:  J Biomol NMR       Date:  1997-12       Impact factor: 2.835

4.  Characterization of the cooperative function of inhibitory sequences in Ets-1.

Authors:  M D Jonsen; J M Petersen; Q P Xu; B J Graves
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

5.  A potential role for Elf-1 in terminal transferase gene regulation.

Authors:  P Ernst; K Hahm; L Trinh; J N Davis; M F Roussel; C W Turck; S T Smale
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  A single amino-acid substitution in the Ets domain alters core DNA binding specificity of Ets1 to that of the related transcription factors Elf1 and E74.

Authors:  R Bosselut; J Levin; E Adjadj; J Ghysdael
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

7.  Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif.

Authors:  L W Donaldson; J M Petersen; B J Graves; L P McIntosh
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

8.  ets-1 in astrocytes: expression and transmitter-evoked phosphorylation.

Authors:  L F Fleischman; L Holtzclaw; J T Russell; G Mavrothalassitis; R J Fisher
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

9.  DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.

Authors:  R A Bailly; R Bosselut; J Zucman; F Cormier; O Delattre; M Roussel; G Thomas; J Ghysdael
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

10.  Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.

Authors:  Kouichi Tabu; Taichi Kimura; Ken Sasai; Lei Wang; Norihisa Bizen; Hiroshi Nishihara; Tetsuya Taga; Shinya Tanaka
Journal:  Mol Cancer       Date:  2010-02-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.